20/05/2026
Pre-filled syringes are no longer just a convenience format.
They are becoming part of how injectable therapies are developed, delivered and scaled.
According to Visiongain analysis, the global pre-filled syringes market is valued at US$9.21 billion in 2026 and projected to reach US$22.18 billion by 2036, growing at a CAGR of 9.2%.
This week’s Market Watch looks at why biologics, self-administration, GLP-1 demand, fill-finish capacity and drug-device innovation are reshaping the market.
What matters most now: usability, supply reliability and ex*****on.
Read the full article: https://visiongain.com/why-pre-filled-syringes-are-becoming-central-to-biologics-strategy/
Pre-filled syringes shift from convenience to strategic biologics delivery platform